Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Gastrointestinal Neoplasms 1Colorectal Neoplasms 1Carcinoma, Renal Cell 1Carcinoma, Hepatocellular 1Advanced Hepatocellular Carcinoma (HCC) 1Acrocephalosyndactylia 1

Interventions

pemigatinib 2pembrolizumab 1derazantinib 1brivanib 1Rogaratinib 1Irinotecan 1Gemcitabine 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Acrocephalosyndactylia × brivanib × Clear all
NCT01367275 2020-09-03

Irinotecan Plus Brivanib in Metastatic Colorectal Cancer (CRC) Enriched for Elevated Levels of Plasma FGF

M.D. Anderson Cancer Center

Phase 2 Terminated
8 enrolled 5 charts
Gastrointestinal

Acrocephalosyndactylia, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡